Fernando Carvalho Neuenschwander

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado et al. · The Lancet · 2021 · 489 citations · Full text

Thrombosis, Covid-19 Pandemic, Patient Safety +9

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 70 citations · Full text

Covid-19 Pandemic, Respiratory Infection, Infectious Respiratory Disease +6

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson et al. · Diabetes Care · 2020 · 42 citations · Full text

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Giulio Francesco Romiti, Bernadette Corica, Marco Proietti et al. · EClinicalMedicine · 2023 · 38 citations · Full text